J.A. Gómez-Gerique

Instituto de Investigación Marqués de Valdecilla — Spain

Medicine · Health Sciences

19h-index1.3kcitations59works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lipoproteins and Cardiovascular Health(15), Diabetes, Cardiovascular Risks, and Lipoproteins(11), Nutritional Studies and Diet(7), Adipokines, Inflammation, and Metabolic Diseases(4), Inflammatory mediators and NSAID effects(4)

Publications59 total

Clinical, biochemical and genetic spectrum of low alkaline phosphatase levels in adults
European Journal of Internal Medicine·2016· 73 citedOpen Access
Estimated Glomerular Filtration Rate in Renal Transplantation
Transplantation·2015· 32 cited
AB0923 Is Adult Hypophosphatasia a Cardiovascular Risk Factor?
Annals of the Rheumatic Diseases·2015
Costs resulting from premature mortality due to cardiovascular causes: A 20-year follow-up of the DRECE study
Revista Clínica Española (English Edition)·2014· 3 cited
Mortalidad prematura cardiovascular y sus costes: 20 años de seguimiento del estudio DRECE
Revista Clínica Española·2014· 2 cited
Pseudo-hypertriglyceridaemia or hyperglycerolemia?
Clínica e Investigación en Arteriosclerosis·2013· 8 cited
AB0231 Rheumatoid arthritis (ra) patients present relevant and diverse alterations in lipid and lipoprotein metabolism associated to cardiovascular (cv) risk: preliminary results
Annals of the Rheumatic Diseases·2013
AB0271 Beneficial effect of anti-tnf therapy in the lipoprotein atherogenic risk profile in comparison with dmard standard therapy in ra patients
Annals of the Rheumatic Diseases·2013
AB0270 Anti-tnf therapy induces positive changes in the lipoprotein profile of ra patientes. results of a prospective study
Annals of the Rheumatic Diseases·2013· 1 cited
Influencia de la inflamación y la presencia de amiloide sobre el metabolismo lipídico en pacientes con artritis reumatoide
Clínica e Investigación en Arteriosclerosis·2012
Concentraciones séricas de marcadores bioquímicos en pacientes intervenidos de derivación biliopancreática
Revista del Laboratorio Clínico·2011
Inflammation markers, chronic kidney disease, and renal replacement therapy.
PubMed·2011· 43 cited
Markers of inflammation before and during peritoneal dialysis.
PubMed·2011· 9 cited
Inflammation Markers, Chronic Kidney Disease, and Renal Replacement
2011
Under-recognized renal insufficiency in hospitalized patients: Implications for care
European Journal of Internal Medicine·2010· 17 cited
Conventional Lipid Profile and Lipoprotein(a) Concentrations in Treated Patients with Rheumatoid Arthritis
The Journal of Rheumatology·2009· 42 citedOpen Access
Diabetes Mellitus is the Main Risk Factor for Early Cardiovascular Mortality among General Population in Spain: Drece follow up Project
Annals of Epidemiology·2007
Coste por año de vida ganado con atorvastatina 10 mg en pacientes hipertensos españoles en riesgo moderado: Evaluación económica del estudio ASCOT-LLA con costes españoles
PharmacoEconomics Spanish Research Articles·2007· 4 cited
Licofelone, a Balanced Inhibitor of Cyclooxygenase and 5-Lipoxygenase, Reduces Inflammation in a Rabbit Model of Atherosclerosis
Journal of Pharmacology and Experimental Therapeutics·2006· 74 cited
Ethanol beverages containing polyphenols decrease nuclear factor kappa-B activation in mononuclear cells and circulating MCP-1 concentrations in healthy volunteers during a fat-enriched diet
Atherosclerosis·2006· 32 cited
page 1 of 3Next →

Frequent Co-authors

Amelia Porres(7), Miguel A. Rubio(6), J.A. Gutiérrez-Fuentes(5), Jordi Ordóñez‐Llanos(5), Xavier Pintó(4), Agustı́n Gómez de la Cámara(4), José Rodrı́guez-Espinosa(4), Luis Miguel Blanco‐Colio(3), Luis A. Álvarez-Sala(3), Jesús Egido(3), Maria Teresa Garcı́a-Unzueta(3), Francesc González‐Sastre(3), Consuelo Fernández‐Miranda(3), Jaime Calvo Alén(3), Carmela Baamonde(3), Carmen Bustos(2), Mónica Ortego(2), Miguel Ángel Hernández-Presa(2), Pilar Cancelas(2), Jesús Millán(2)